glp-1 dementia Medications Associated with Reduced Likelihood of Compared to Other Diabetic Meds GLP-1 Dementia Risk: Hype or

Animal data on a GLP-1/GIP/glucagon triple agonist show strong effects on body weight reduction, and glucose- and lipid normalization in rodents

Given that the half-life of SGLT2 inhibitors varies from 11 to 13 hours, it seems reasonable to withhold these medications for three days (or five half-lives) before elective surgery

If you have a B12 deficiency, thats likely the cause for your anemia in the first place

Endocrinology 156 , 847857 (2014)

For some researchers, the additional weight loss from higher doses is not worth the increased side effect burden, and a dose between 1.0 and 1.7 mg represents their personal optimal balance

As a result, cell viability increased from about 40% in the erastin-treated group to nearly 80% at 50 M dopamine, thereby effectively suppressing ferroptosis (129)